JENNIFER THUERMER: Open Payments
NPI 1295745438 · SARASOTA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$729 in 18 payments from 12 companies in 2025. Trend: 2023 $339 · 2024 $396 · 2025 $729
Food & beverage: $729
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $174 |
| Edwards Lifesciences Corporation | 1 | $171 |
| Alnylam Pharmaceuticals Inc. | 1 | $125 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $56 |
| Esperion Therapeutics, Inc. | 2 | $43 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $32 |
| SCPHARMACEUTICALS INC. | 1 | $28 |
| BridgeBio Pharma, Inc. | 1 | $25 |
| Davol Inc. | 1 | $21 |
| PFIZER INC. | 1 | $20 |
Products named: CAMZYOS, PASCAL, AMVUTTRA, JARDIANCE, NEXLETOL, LifeVest, FUROSCIX, Attruby.
Industry payments across FL — which companies pay providers there.
